AbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

AbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in two - is selling $14.7B in one of the biggest-ever dollar-denominated debt issues in the US high-grade market. The company is offering three-year fixed-rate, three-year floating-rate, five-year, six-year, 10-year and 30-year notes in a six-part deal that is expected to price later today.